Stupid statements? You're a schmuck. You really think this stock is trading in a healthy fashion? Fine. But god help you when a correction cones and you become-what's that label?-a bag holder. You're obviously blind.
This stock is b.s. They get Okrambi approval and the stock trades lower??!! Biotech ETF IBB way up today and this stock is $2-$3 lower??!! One analyst says $160 another says $85?!! Risk not worth the lack of reward. This is the problem with the market right now and for the last 18 months. Companies deliver good earnings, good news and shareholders are not rewarded. This is unacceptable and if you people reading this can't understand this, then be ready to bleed. A correction is coming and add to this stock stalling indefinitely at these prices, the worst has yet to come.
Hey, you are still around? I thought you promised to sell it when it gets approved. When are you going to sell it, so we can breath. Your stupid statements are driving us nuts. We are investors not traders.
Sentiment: Strong Buy
Rojo, this was all over the internet. Hope you picked up that it is years away. How expensive is it, is it ongoing inhalation. 3.5% is equivalent to what VRTX drugs provide NOW. What if VRTX triples and newer modalities go beyond 3.5%...Ireland was happy with 3.5% from this study., well that means they will pay for that now with Orkambi.
Genius, every CF patient eligible to receive this drug will be taking it within the next 90 days. Every one! Time to get burned badly shortie.
The key word is "improvement". This is the alternative to inevitable "decline" Do you have a family member with CF? I would guess not. What's your point?
Glad I am owning this at $40 average price. Mark my word. This drug will sale $4+ Billion rate + .6B current drug sale at end of year. with about 10-15% growth for next 4-5 year. Given high margin and low cost marketing, this itself worth $50-$60 Billion in market cap. (Buyout would occur around $60-$70 Billion. that equal to $250. My reasonable estimate is, once script known, it will trade around $180 (In 6 month, script trend should known). That is 30%+ upside with minimum downside. Buy as many as you can.
Sentiment: Strong Buy
Like Kevin O'Leary says on Shark Tank "I Like Money".
I own the following Bio stocks:
Amgen 55% @$46 average since 1995
Gilead 20% @$52 average since 2014
Celgene 20% @$70 average since 2014
Vertex 5% @90 average since 2014
The reason I do not have too much money in VRTX is like Kevin said "SHOW ME THE MONEY!". I will invest more as they show progress.
Vertex charges $259,000, every year, for a 2% improvement with the side effects that caused half to drop out thrown in for free.